Project 2025 Tracker / What’s done, what’s next

14. Department of Health and Human Services · Notable

Prohibit brand-name makers from parking first-to-file generic rights

Not started

“Specifically, the FDA should prohibit pharmaceutical companies from purposely sitting on their legally available right to be the first to sell generic versions of their drugs.”

What has happened

  1. Not started

    No action found yet. This entry is the starting point, not a finding.

Action
restrict
Object
first-to-file generic marketing rights
ID
1224